Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away ...

DelveInsight’s Smart Inhalers Market Insights report provides the current and forecast market analysis, individual leading ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

People with asthma, chronic obstructive pulmonary disease (COPD), and certain other respiratory conditions typically receive Medicare coverage for inhalers. To receive coverage, a person must have ...

With Medicare coverage, a person can still have certain out-of-pocket costs for an inhaler. Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

smart inhalers market report highlights transformative digital innovations in respiratory care, improved patient adherence, and forecasted growth through 2035 ...

Timing the use of a commonly prescribed asthma inhaler in the mid-afternoon could lead to improved clinical outcomes, according to research.

you are more likely to have asthma than COPD. If there is no improvement, a doctor may try to switch your medications. If there is still no improvement, they may suspect you have, in fact ...

Jan. 21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising concerns for the efficacy of these medications for maternal ...